
Related Posts

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

The COVID-19 pandemic forced discussions about social determinants of health (SDOH) back into the forefront of healthcare discussions. Knowing that 80% of a person’s health outcomes are impacted by these external factors – economic, social, community, education, and more – we, as industry leaders, must shift these discussions about SDOH implementation from a lofty goal into a reality. How do we get there?

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Patients taking opioid dosages at or above 50 MME/day are twice as likely to overdose compared to those taking 20 MME/day, and the risk further increases as the MME/day increases.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

Recent federal legislative and regulatory updates in managed care pharmacy have prioritized topics ranging from expedited access to novel therapeutics to the health disparities and equity concerns affecting patient populations nationwide, but progress on these developments will depend on the impact of the midterm elections

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.